BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Biotech Bay

  The 6 Most In-Demand Life Sciences Jobs Right Now

  A closer look at the six jobs in life sciences that are currently in high demand.

  October 23, 2017

   · 

  4 min read

   · 

  Alex Keown
• 

  Drug Development

  DBV Technologies Crashed as Allergy Drug Flunked Phase III Test

  DBV’s share price crumbled over the weekend after its Phase III peanut allergy trial failed to show a statistically significant response against placebo.

  October 23, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  BioMidwest

  These 3 Gene Therapy Biotechs Could Make Investors Rich

  Immuno-oncology and gene therapy has been a hot field for the last few years, and the approval of the first CAR-T therapies has only set the kindling ablaze.

  October 23, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Amgen’s KYPROLIS Meets Goals in Phase III Multiple Myeloma Study

  A late-stage study shows that a stronger weekly dose of Amgen’s Kyprolis combined with dexamethasone had a greater progression-free survival benefit than a twice-weekly dose of the drug at the approved dosing level.

  October 23, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Scott Gottlieb’s Meteoric Rise?

  A look at FDA head Scott Gottlieb’s career so far.

  October 23, 2017

   · 

  1 min read

   · 

  Karl Thiel
• 

  FDA

  Alexion Wins Expanded Approval for Blockbuster Drug Soliris

  Alexion is set to secure even more revenue from its blockbuster drug Soliris, the most expensive drug in the world.

  October 23, 2017

   · 

  3 min read

   · 

  Alex Keown
• 

  Deals

  Takeda’s Partner Merges With Crestovo to Form Finch Therapeutics Group

  Two privately-held biotechs have merged to tackle recurrent C. difficile infections.

  October 23, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Career Advice

  Tips on How to Get Hired From Roche

  Here is how you can land a job at one of the biggest pharmaceuticals in the world.

  October 23, 2017

   · 

  4 min read

   · 

  Mark Terry
• 

  Drug Development

  Lysogene Pushes Forward With Sanfilippo Syndrome Study, Establishes Footprint in U.S.

  Finding a treatment for Sanfilippo Syndrome is a personal matter for the Lysogene team.

  October 23, 2017

   · 

  4 min read

   · 

  Alex Keown
• 

  Drug Development

  Mis-Matched Expectations With Celgene, Ionis

  The drug developed by Nogra always seemed like a longshot, but Celgene management talked it up over the years as it advanced.

  October 23, 2017

   · 

  1 min read

   · 

  Karl Thiel